Summary by Moomoo AI
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], engaged in multiple acquisition transactions of the company's common stock on February 13, 2024. Burnett acquired a total of 192,050 shares through these transactions, which were classified as grants or awards. Following these acquisitions, Burnett's direct holdings in Arcutis Biotherapeutics' common stock increased to 274,082 shares. The transactions reflect a significant increase in Burnett's stake in the company, indicating a potential strengthening of the insider's commitment to the firm's future.